InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Royalty Pharma plc

RPRX Clue Score47
United States Fiscal year ends December CIK 0001802768 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Pablo G. Legorreta
28 Jun 2023
CEO, Chairman of the Board
Buy indirect
130,000
$29.51
$3.84M
Pablo G. Legorreta
13 Jun 2023
CEO, Chairman of the Board
Buy indirect
45,000
$32.78
$1.47M
Pablo G. Legorreta
12 Jun 2023
CEO, Chairman of the Board
Buy indirect
45,000
$33.00
$1.48M
Pablo G. Legorreta
24 May 2023
CEO, Chairman of the Board
Buy indirect
150,000
$32.25
$4.84M
Pablo G. Legorreta
17 May 2023
CEO, Chairman of the Board
Buy indirect
69,612
$32.94
$2.29M
Pablo G. Legorreta
16 May 2023
CEO, Chairman of the Board
Buy indirect
160,388
$33.57
$5.38M
Henry A Fernandez
24 Feb 2022
Director
Buy indirect
32,500
$37.49
$1.22M
Showing 250 of 279 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 307
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 81
Sales straight out of an exercise 1
Sales at will 178
Transactions with no price 0
Shares from compensation/vesting 128,876,253
Sales filed before the plan box existed 162
History held since 17 Jun 2020